Progenika to Develop Companion Dx for AMT Gene Therapy

The DNA-chip technology will diagnose patients with LPL deficiency who may benefit from AMT's treatment.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.